Ketamine Use in Palliative Care #132

Mao J , Price DD , Mayer DJ . Mechanisms of hyperalgesian and morphine tolerance: A current view of their possible interactions. Pain, 1995; 62:259–274.

Wolff K , Winstock AR . Ketamine: From medicine to misuse. CNS Drugs, 2006; 20:199–218.

Kronenberg RH . Ketamine as an Analgesic. J Pain & Palliat Care Pharmaco, 2002; 16:27–35.

Taylor BJ , Orr SA , Chapman JL , Fisher DE . Beyond-use dating of extemporaneously compounded ketamine, acepromazine, and xylazine: Safety, stability, and efficacy over time. J Am Assoc Lab An Sci, 2009; 48:718.

Okon T . Ketamine: An introduction for a pain and palliative medicine physician. Pain Phys, 2007; 10:493.

Dickman A , Schneider J , Varga J . The syringe driver: Continuous subcutaneous infusions in palliative care. New York: Oxford University Press, 2005.

Hijazi Y , Boulieu R . Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes. Drug Metab and Dispos, 2002; 30:853.

Kotlinska-Lemieszek A , Luczak J . Subanesthetic ketamine: An essential adjuvant for intractable cancer pain. J Pain Symptom Manage, 2004; 28:100–102.

Bell RF , Eccleston C , Kalso E . Ketamine as adjuvant to opioids for cancer pain: A qualitative systematic review. J Pain Symptom Manage, 2003; 26:867–875.